A new patent licencing deal between Cornell and LNC Therapeutics will help the French biotech become the ‘must have’ partner for research and product development relating to the Christensenella strain, says the company’s CEO.
New analysis looking into the effect of Lallemand’s Lactobacillus helveticus Lafti L10 probiotic reveals an antioxidant potential that may interest athletes in the periods before or during strenuous exercise.
Gut dysbiosis is a common feature of the afflictions that come with aging, according a recent Japanese review. The finding opens wider the door for probiotics and prebiotics in a healthy aging positioning.
Immigrants and refugees moving from Southeast Asia to the US demonstrate a ‘westernisation’ of their gut microbiota, a study finds, that could provide insight into metabolic health issues affecting newcomers.